Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CombiMatrix and SAIC to Jointly Develop Biothreat Identification Microarrays.


NEWPORT BEACH, Calif. -- Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG ACTG Acting
ACTG AIDS Clinical Trial Group
ACTG Actuating/Actuator
) announced today that its CombiMatrix group and Science Applications International Corporation (SAIC SAIC - http://saic.com. ), the nation's largest employee-owned research and engineering company, will work together to develop microarrays for the identification of multiple biothreat organisms. Both companies have Department of Defense (DoD) contracts from the Defense Threat Reduction Agency The Defense Threat Reduction Agency (or DTRA) is a combat support agency of the United States Department of Defense (DoD) whose primary function is to analyze potential threats to the United States, both homeland and abroad, and provide contingency plans for all such  that support the development and delivery of complementary products. Leveraging their respective DoD funding can help expedite the development and testing of new identification and diagnostic assays and products against conventional biothreat agents and emerging and genetically engineered genetically engineered adjective Recombinant, see there  pathogens.

SAIC has developed a genome assay and data mining tools that identify genomic sequences that are unique to specific microbial microbial

pertaining to or emanating from a microbe.


microbial digestion
the breakdown of organic material, especially feedstuffs, by microbial organisms.
 biothreat agents. Dr. R. Paul Schaudies, SAIC Vice President of Chemical and Biological Defense, explained, "By combining the bioinformatics of our proprietary Fast Identification of Unique Genomic Regions (FIGUR) software with a highly-multiplexed microarray we can hopefully make false positive readings a thing of the past. Protocols and procedures, along with microarrays, will be transferred to government laboratories for independent validation."

CombiMatrix has developed a microarray platform, based upon complementary metal oxide semiconductor See CMOS.

(integrated circuit) Complementary Metal Oxide Semiconductor - (CMOS) A semiconductor fabrication technology using a combination of n- and p-doped semiconductor material to achieve low power dissipation.
 (CMOS (Complementary Metal Oxide Semiconductor) Pronounced "c-moss." The most widely used integrated circuit design. It is found in almost every electronic product from handheld devices to mainframes. ) technology. Through proprietary instrumentation and probe design software, CombiMatrix can produce single or multiple microarrays with unique DNA sequences on each of its 12,000 features. This gives the customer a rapid and versatile approach to defining and changing microarray array content. Under the DoD contract, CombiMatrix is developing electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies.

e·lec·tro·chem·i·cal
adj.
 detection as an alternative to the current use of large and expensive optical readers and dyes used in fluorescence detection.

"We are pleased to be working with SAIC towards a common goal that will benefit the DoD and our nation," said Dr. David Danley, Director of Homeland Security and Defense Programs for CombiMatrix. "This effort allows us to leverage our DoD resources using proven assays and technologies. When we have completed development of electrochemical detection, we will then be able to move genomic assays out of the lab and into the field."

ABOUT SAIC

SAIC is the nation's largest employee-owned research and engineering company, providing information technology, systems integration and eSolutions to commercial and government customers. SAIC engineers and scientists work to solve complex technical problems in national and homeland security, energy, the environment, space, telecommunications, health care, transportation and logistics. With annual revenues of $6.7 billion, SAIC and its subsidiaries, including Telcordia Technologies, have more than 44,000 employees at offices in more than 150 cities worldwide. More information about SAIC can be found on the Internet at www.saic.com.

ABOUT ACACIA RESEARCH CORPORATION

Acacia Research Corporation comprises two operating groups: Acacia Technologies Group and CombiMatrix Group.

The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 synthesis/diagnostics, siRNA synthesis, drug discovery, and immunochemical im·mu·no·chem·is·try  
n.
The chemistry of immunologic phenomena, as of antigen-antibody reactions.



im
 detection. CombiMatrix provides DNA arrays to researchers under the CustomArray(TM) brand. CombiMatrix's Express Track(SM) drug discovery program is a systems biology approach, using its technology, to target common viral diseases with siRNA compounds.

The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia's DMT See DSL. (R) technology, which is supported by 5 U.S. and 31 foreign patents, relates to audio and audio/video transmission and receiving systems commonly known as audio-on-demand, video-on-demand, and audio/video streaming, and is used for distributing digital content via several means including Internet, cable, satellite and wireless systems. Acacia's Internet Access Redirection ("IAR IAR - Instruction Address Register.

The IBM name for program counter.
") technology covers redirected Internet registrations commonly used at wireless hotspots and hotels.

Acacia Research-Acacia Technologies (Nasdaq: ACTG) and Acacia Research-CombiMatrix (Nasdaq: CBMX) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.

Information about the Acacia Technologies Group and the CombiMatrix Group is available at www.acaciaresearch.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the economic slowdown affecting technology companies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
, recent and forthcoming Quarterly Reports on Form 10-Q, recent Current Reports on Forms 8-K and 8-K/A, and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 14, 2004
Words:829
Previous Article:Intergraph Public Safety Selected to Provide Integrated Incident Management System to Wichita Falls, Texas Advanced Technology to Manage the Public...
Next Article:Mindspeed's Fiscal 2004 Fourth Quarter Earnings Conference Call; Monday, Oct. 25, 2004; 2 p.m. Pacific Daylight Time / 5 p.m. Eastern Daylight Time.



Related Articles
CombiMatrix Announces Sale of DNA Micorarray Synthesizer to Keio University.
CombiMatrix and CBRC Develop Methylation Detection Technology.
CombiMatrix Announces Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases.
Acacia Research Reports Fourth Quarter and Year End Financial Results.
CombiMatrix Enters into Marketing Relationship with Axon Instruments.
Rapid sample screening for first responders and health officials.
CombiMatrix Begins Work on $2.1 Million Department of Defense Contract.
Identifying influenza viruses with resequencing microarrays.
CombiMatrix Begins Work on $1.9 Million U.S. Army Contract.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles